Correlation between KRAS mutation status and response to chemotherapy in patients with advanced non-small cell lung cancer☆.

MLA

Hames, Megan L., et al. “Correlation between KRAS Mutation Status and Response to Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer☆.” Lung Cancer (01695002), vol. 92, Feb. 2016, pp. 29–34. EBSCOhost, https://doi.org/10.1016/j.lungcan.2015.11.004.

APA

Hames, M. L., Chen, H., Iams, W., Aston, J., Lovly, C. M., & Horn, L. (2016). Correlation between KRAS mutation status and response to chemotherapy in patients with advanced non-small cell lung cancer☆. Lung Cancer (01695002), 92, 29–34. https://doi.org/10.1016/j.lungcan.2015.11.004

Chicago

Hames, Megan L., Heidi Chen, Wade Iams, Jonathan Aston, Christine M. Lovly, and Leora Horn. 2016. “Correlation between KRAS Mutation Status and Response to Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer☆.” Lung Cancer (01695002) 92 (February): 29–34. doi:10.1016/j.lungcan.2015.11.004.